Anti-inflammatory Effects of Oct4/Sox2-overexpressing Human Adipose Tissue-derived Mesenchymal Stem Cells
Affiliations
Background/aim: The transcription factors Oct4 and Sox2 enhance the proliferation and pluripotency of human adipose tissue-derived mesenchymal stem cells (hAT-MSCs); however, the anti-inflammatory effects of Oct4- and Sox2-overexpressing hAT-MSCs (Oct4/Sox2-hAT-MSCs) are unclear. Here, we evaluated the anti-inflammatory effects of Oct4/Sox2-hAT-MSCs in vitro and in vivo.
Materials And Methods: Supernatants from green-fluorescent protein (GFP)- and Oct4/Sox2-hAT-MSCs were used to treat lipopolysaccharide (LPS)-stimulated RAW264.7 cells and inflammatory cytokine expression was determined. In LPS-induced mice, GFP- and Oct4/Sox2-hAT-MSCs were injected intraperitoneally and survival rates, as well as sickness scores of mice, were monitored.
Results: Decreased expression of pro-inflammatory cytokines was observed in Oct4/Sox2-hAT-MSC supernatant-exposed RAW264.7 cells compared to that in GFP-hAT-MSC supernatant-exposed RAW264.7 cells. The sickness score was reduced to 34.9% and the survival rate was increased by 11.1% in Oct4/Sox2-hAT-MSC-injected mice compared to that in GFP-hAT-MSC-injected mice.
Conclusion: Our findings provide important insights into the development of therapies utilizing Oct4/Sox2-hAT-MSCs in inflammatory diseases.
Khosravi Z, Mirzaeian L, Taghi Ghorbanian M, Rostami F Cell Biochem Biophys. 2024; 82(3):2585-2595.
PMID: 38963603 DOI: 10.1007/s12013-024-01372-z.
Possibilities and efficiency of MSC co-transfection for gene therapy.
Christoffers S, Seiler L, Wiebe E, Blume C Stem Cell Res Ther. 2024; 15(1):150.
PMID: 38783353 PMC: 11119386. DOI: 10.1186/s13287-024-03757-6.
Yotsumoto F, Yoshikawa K, Hirakawa T, Urushiyama D, Kiyoshima C, Arima H Cureus. 2024; 16(3):e57220.
PMID: 38559528 PMC: 10980580. DOI: 10.7759/cureus.57220.
Pechacek K, Vonder Haar C Physiol Behav. 2022; 257:113998.
PMID: 36257462 PMC: 11305111. DOI: 10.1016/j.physbeh.2022.113998.
Matta A, Nader V, Lebrin M, Gross F, Prats A, Cussac D Cells. 2022; 11(10).
PMID: 35626657 PMC: 9140025. DOI: 10.3390/cells11101620.